Economic Impact of Cancer in the United States
- 12 October 2006
- book chapter
- Published by Oxford University Press (OUP)
Abstract
This chapter discusses the economic impact of cancer in the United States. Three categories of cost domains are identified: direct costs, resulting from the use of resources for medical care; indirect costs, resulting from the loss of economic resources and opportunities associated with disease and treatment; and psychosocial costs, such as pain and suffering. The measurement of health care costs, source of data on the costs of medical care, and approaches to estimating the economic burden of cancer are discussed.Keywords
This publication has 59 references indexed in Scilit:
- Breast cancer survival, work, and earningsJournal of Health Economics, 2002
- Race, Socioeconomic Status, and Breast Cancer Treatment and SurvivalJNCI Journal of the National Cancer Institute, 2002
- Costs of Treatment for Elderly Women With Early-Stage Breast Cancer in Fee-for-Service SettingsJournal of Clinical Oncology, 2002
- Cost Comparison of Mastectomy Versus Breast-Conserving Therapy for Early-Stage Breast CancerJNCI Journal of the National Cancer Institute, 2001
- The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case studyHealth Economics, 2001
- Determining Costs of Health Care Services for Cost-Effectiveness AnalysesMedical Care, 1999
- Prospective economic evaluation accompanying a trial of GM-CSF/IL-3 in patients undergoing autologous bone marrow transplantation for Hodgkin’s and non-Hodgkin’s lymphomaBone Marrow Transplantation, 1998
- Clinical surveillance for early stage breast cancer: An analysis of claims dataBreast Cancer Research and Treatment, 1996
- The friction cost method for measuring indirect costs of diseaseJournal of Health Economics, 1995
- The cost of cancerThe Laryngoscope, 1979